gastroparesis syndrome
Conditions
Interventions
the "Hewei Tongjiang" acupuncture group:Acupuncture was applied to Zhongwan (CV 12) Xiawan (CV 12) and Shuanmen (bilateral) with a depth of 1.5 cun (about 40mm). The needles were maintained for 30 min
bdominal superficial stabbing group:Acupuncture was applied to Zhongwan (CV 12) Xiawan (CV 12) and Shuanmen (bilateral) with a depth of 0.5 cun (about 10mm). The needles were retained for 30 minutes a
Waiting for treatment group:In the blank control group no abdominal acupuncture was performed during the visit and abdominal acupuncture compensation treatment was given 12 times after the visit
Sponsors
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
35 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Age 35 to 70 years old gender is not limited; (2) Comply with the diagnosis of stroke and within 14~90 days of the first stroke; (3) Meet the diagnostic criteria for symptoms of gastroparesis syndrome and the relevant symptoms occurred after the stroke; (4) Nasogastric tube was left in place; (5) Consciousness cooperation in medical examination no aphasia and severe cognitive impairment; (6) The informed consent process was in accordance with the regulations and the informed consent form was signed.
Exclusion criteria
Exclusion criteria: (1) Those who suffered from functional dyspepsia peptic ulcer severe heterogeneous hyperplasia of gastric mucosa gastrointestinal tumors or other organic lesions of the gastrointestinal tract and those who had undergone gastrointestinal surgeries such as partial gastrectomy before the stroke; (2) Diabetic patients with fasting blood glucose more than 10mmol/L 2 hours after meal blood glucose more than 11.1mmol/L or any time blood glucose value more than 8.5mmol/L; (3) Combination of severe peptic ulcer positive fecal occult blood vomiting blood; (4) Received treatment for gastroparesis or dyspepsia within the last 2 weeks or taken drugs that affect gastrointestinal motility or gastric acid secretion including but not limited to proton pump inhibitors and dopamine receptor antagonists; (5) Those who have a combination of serious heart disease liver dysfunction renal insufficiency haematopoietic system and metabolic system and other serious diseases or whose vital signs are unstable; (6) Those with a combination of severe anxiety depressive state or dementia; (7) Pregnant or lactating women; (8) Those who in the judgement of the investigator should not be enrolled in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| gastroparesis cardinal symptom indexGCSI; | — |
Secondary
| Measure | Time frame |
|---|---|
| motilin;acupuncture efficacy;Changes in electrogastrogram parameters;gastrin;Changes in gastric residual volume;ZUNG's Anxiety Self-Rating Scale;Nutritional Risk Screening NRS 2002 scale score;neurologic deficit score (NIHSS);ZUNG's Depression Self-Rating Scale;Leeds Dyspepsia Questionnaire score;vasoactive intestinal peptide; | — |
Countries
China
Contacts
Public ContactDAI Xiaoyu
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Outcome results
None listed